The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Human Prothrombin Complex-Global Market Insights and Sales Trends 2025
Synopsis
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
The global Human Prothrombin Complex market size is expected to reach US$ 3473.8 million by 2029, growing at a CAGR of 11.8% from 2023 to 2029. The market is mainly driven by the significant applications of Human Prothrombin Complex in various end use industries. The expanding demands from the Hemophilia B, Vitamin K Deficiency and Others,, are propelling Human Prothrombin Complex market. 500 IU/Vial, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 600 IU/Vial segment is estimated at % CAGR for the next seven-year period.
Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Prothrombin Complex, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Prothrombin Complex market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Prothrombin Complex market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Prothrombin Complex sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Prothrombin Complex covered in this report include Takeda, CSL, Grifols, Octapharma, Hualan Biological and Meheco Xinxing Pharma, etc.
The global Human Prothrombin Complex market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda
CSL
Grifols
Octapharma
Hualan Biological
Meheco Xinxing Pharma
Global Human Prothrombin Complex market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Prothrombin Complex market, Segment by Type:
500 IU/Vial
600 IU/Vial
1000 IU/Vial
Others
Global Human Prothrombin Complex market, by Application
Hemophilia B
Vitamin K Deficiency
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Human Prothrombin Complex manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Human Prothrombin Complex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
The global Human Prothrombin Complex market size is expected to reach US$ 3473.8 million by 2029, growing at a CAGR of 11.8% from 2023 to 2029. The market is mainly driven by the significant applications of Human Prothrombin Complex in various end use industries. The expanding demands from the Hemophilia B, Vitamin K Deficiency and Others,, are propelling Human Prothrombin Complex market. 500 IU/Vial, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 600 IU/Vial segment is estimated at % CAGR for the next seven-year period.
Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Prothrombin Complex, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Prothrombin Complex market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Prothrombin Complex market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Prothrombin Complex sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Prothrombin Complex covered in this report include Takeda, CSL, Grifols, Octapharma, Hualan Biological and Meheco Xinxing Pharma, etc.
The global Human Prothrombin Complex market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda
CSL
Grifols
Octapharma
Hualan Biological
Meheco Xinxing Pharma
Global Human Prothrombin Complex market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Prothrombin Complex market, Segment by Type:
500 IU/Vial
600 IU/Vial
1000 IU/Vial
Others
Global Human Prothrombin Complex market, by Application
Hemophilia B
Vitamin K Deficiency
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Human Prothrombin Complex manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Human Prothrombin Complex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Human Prothrombin Complex Market Overview
1.1 Human Prothrombin Complex Product Overview
1.2 Human Prothrombin Complex Market Segment by Type
1.2.1 500 IU/Vial
1.2.2 600 IU/Vial
1.2.3 1000 IU/Vial
1.2.4 Others
1.3 Global Human Prothrombin Complex Market Size by Type
1.3.1 Global Human Prothrombin Complex Market Size Overview by Type (2018-2029)
1.3.2 Global Human Prothrombin Complex Historic Market Size Review by Type (2018-2023)
1.3.3 Global Human Prothrombin Complex Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Human Prothrombin Complex Sales Breakdown by Type (2018-2023)
1.4.2 Europe Human Prothrombin Complex Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Human Prothrombin Complex Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Human Prothrombin Complex Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Human Prothrombin Complex Sales Breakdown by Type (2018-2023)
2 Global Human Prothrombin Complex Market Competition by Company
2.1 Global Top Players by Human Prothrombin Complex Sales (2018-2023)
2.2 Global Top Players by Human Prothrombin Complex Revenue (2018-2023)
2.3 Global Top Players by Human Prothrombin Complex Price (2018-2023)
2.4 Global Top Manufacturers Human Prothrombin Complex Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Prothrombin Complex Market Competitive Situation and Trends
2.5.1 Human Prothrombin Complex Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Human Prothrombin Complex Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Prothrombin Complex as of 2022)
2.7 Date of Key Manufacturers Enter into Human Prothrombin Complex Market
2.8 Key Manufacturers Human Prothrombin Complex Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Human Prothrombin Complex Status and Outlook by Region
3.1 Global Human Prothrombin Complex Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Human Prothrombin Complex Historic Market Size by Region
3.2.1 Global Human Prothrombin Complex Sales in Volume by Region (2018-2023)
3.2.2 Global Human Prothrombin Complex Sales in Value by Region (2018-2023)
3.2.3 Global Human Prothrombin Complex Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Human Prothrombin Complex Forecasted Market Size by Region
3.3.1 Global Human Prothrombin Complex Sales in Volume by Region (2024-2029)
3.3.2 Global Human Prothrombin Complex Sales in Value by Region (2024-2029)
3.3.3 Global Human Prothrombin Complex Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Human Prothrombin Complex by Application
4.1 Human Prothrombin Complex Market Segment by Application
4.1.1 Hemophilia B
4.1.2 Vitamin K Deficiency
4.1.3 Others
4.2 Global Human Prothrombin Complex Market Size by Application
4.2.1 Global Human Prothrombin Complex Market Size Overview by Application (2018-2029)
4.2.2 Global Human Prothrombin Complex Historic Market Size Review by Application (2018-2023)
4.2.3 Global Human Prothrombin Complex Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Human Prothrombin Complex Sales Breakdown by Application (2018-2023)
4.3.2 Europe Human Prothrombin Complex Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Human Prothrombin Complex Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Human Prothrombin Complex Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Human Prothrombin Complex Sales Breakdown by Application (2018-2023)
5 North America Human Prothrombin Complex by Country
5.1 North America Human Prothrombin Complex Historic Market Size by Country
5.1.1 North America Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Human Prothrombin Complex Sales in Volume by Country (2018-2023)
5.1.3 North America Human Prothrombin Complex Sales in Value by Country (2018-2023)
5.2 North America Human Prothrombin Complex Forecasted Market Size by Country
5.2.1 North America Human Prothrombin Complex Sales in Volume by Country (2024-2029)
5.2.2 North America Human Prothrombin Complex Sales in Value by Country (2024-2029)
6 Europe Human Prothrombin Complex by Country
6.1 Europe Human Prothrombin Complex Historic Market Size by Country
6.1.1 Europe Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Human Prothrombin Complex Sales in Volume by Country (2018-2023)
6.1.3 Europe Human Prothrombin Complex Sales in Value by Country (2018-2023)
6.2 Europe Human Prothrombin Complex Forecasted Market Size by Country
6.2.1 Europe Human Prothrombin Complex Sales in Volume by Country (2024-2029)
6.2.2 Europe Human Prothrombin Complex Sales in Value by Country (2024-2029)
7 Asia-Pacific Human Prothrombin Complex by Region
7.1 Asia-Pacific Human Prothrombin Complex Historic Market Size by Region
7.1.1 Asia-Pacific Human Prothrombin Complex Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Human Prothrombin Complex Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Human Prothrombin Complex Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Human Prothrombin Complex Forecasted Market Size by Region
7.2.1 Asia-Pacific Human Prothrombin Complex Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Human Prothrombin Complex Sales in Value by Region (2024-2029)
8 Latin America Human Prothrombin Complex by Country
8.1 Latin America Human Prothrombin Complex Historic Market Size by Country
8.1.1 Latin America Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Human Prothrombin Complex Sales in Volume by Country (2018-2023)
8.1.3 Latin America Human Prothrombin Complex Sales in Value by Country (2018-2023)
8.2 Latin America Human Prothrombin Complex Forecasted Market Size by Country
8.2.1 Latin America Human Prothrombin Complex Sales in Volume by Country (2024-2029)
8.2.2 Latin America Human Prothrombin Complex Sales in Value by Country (2024-2029)
9 Middle East and Africa Human Prothrombin Complex by Country
9.1 Middle East and Africa Human Prothrombin Complex Historic Market Size by Country
9.1.1 Middle East and Africa Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Human Prothrombin Complex Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Human Prothrombin Complex Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Human Prothrombin Complex Forecasted Market Size by Country
9.2.1 Middle East and Africa Human Prothrombin Complex Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Human Prothrombin Complex Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Takeda
10.1.1 Takeda Company Information
10.1.2 Takeda Introduction and Business Overview
10.1.3 Takeda Human Prothrombin Complex Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Takeda Human Prothrombin Complex Products Offered
10.1.5 Takeda Recent Development
10.2 CSL
10.2.1 CSL Company Information
10.2.2 CSL Introduction and Business Overview
10.2.3 CSL Human Prothrombin Complex Sales, Revenue and Gross Margin (2018-2023)
10.2.4 CSL Human Prothrombin Complex Products Offered
10.2.5 CSL Recent Development
10.3 Grifols
10.3.1 Grifols Company Information
10.3.2 Grifols Introduction and Business Overview
10.3.3 Grifols Human Prothrombin Complex Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Grifols Human Prothrombin Complex Products Offered
10.3.5 Grifols Recent Development
10.4 Octapharma
10.4.1 Octapharma Company Information
10.4.2 Octapharma Introduction and Business Overview
10.4.3 Octapharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Octapharma Human Prothrombin Complex Products Offered
10.4.5 Octapharma Recent Development
10.5 Hualan Biological
10.5.1 Hualan Biological Company Information
10.5.2 Hualan Biological Introduction and Business Overview
10.5.3 Hualan Biological Human Prothrombin Complex Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Hualan Biological Human Prothrombin Complex Products Offered
10.5.5 Hualan Biological Recent Development
10.6 Meheco Xinxing Pharma
10.6.1 Meheco Xinxing Pharma Company Information
10.6.2 Meheco Xinxing Pharma Introduction and Business Overview
10.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Products Offered
10.6.5 Meheco Xinxing Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Human Prothrombin Complex Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Human Prothrombin Complex Industrial Chain Analysis
11.4 Human Prothrombin Complex Market Dynamics
11.4.1 Human Prothrombin Complex Industry Trends
11.4.2 Human Prothrombin Complex Market Drivers
11.4.3 Human Prothrombin Complex Market Challenges
11.4.4 Human Prothrombin Complex Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Human Prothrombin Complex Distributors
12.3 Human Prothrombin Complex Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
